• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, May 12, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Moonshot Goal 1: the 2nd International Symposium on Cybernetic Avatars: September 30

Bioengineer by Bioengineer
September 15, 2022
in Science News
Reading Time: 2 mins read
0
International Symposium on Cybernetic Avatars
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Moonshot Research and Development Program launched by the Cabinet Office of Japan promotes high-risk, high-impact R&D aiming to achieve ambitious Moonshot Goals and solve issues facing future society such as super-aging populations and global warming. Moonshot Goal 1, led by Program Director HAGITA Norihiro, aims to realize “a society in which human beings can be free from limitations of body, brain, space, and time by 2050”. It focuses on cybernetic avatars that will allow anyone to augment their physical, cognitive, and perceptional capabilities and participate actively in society. The Second International Symposium will introduce state-of-the-art cybernetic avatar technology, featuring talks and panel discussions from eminent researchers in the field.

International Symposium on Cybernetic Avatars

Credit: Japan Science and Technology Agency

The Moonshot Research and Development Program launched by the Cabinet Office of Japan promotes high-risk, high-impact R&D aiming to achieve ambitious Moonshot Goals and solve issues facing future society such as super-aging populations and global warming. Moonshot Goal 1, led by Program Director HAGITA Norihiro, aims to realize “a society in which human beings can be free from limitations of body, brain, space, and time by 2050”. It focuses on cybernetic avatars that will allow anyone to augment their physical, cognitive, and perceptional capabilities and participate actively in society. The Second International Symposium will introduce state-of-the-art cybernetic avatar technology, featuring talks and panel discussions from eminent researchers in the field.

Details

Date & Time: Friday September 30th 2022, 10:30-18:15 (Japan Standard Time, UTC+9)

Venue: Campus Plaza Kyoto & Zoom Webinar

Registration: https://form.jst.go.jp/enquetes/MS1sympo2022

Registration deadline: Monday September 26th 2022

Host: Japan Science and Technology Agency

Language: English

Program (TBD)

Session 1: Research activities on Cybernetic Avatars (CA)

Session 2: Keynote and guest speeches

    (Keynote speech) Professor Paolo Dario, Scuola Superiore Sant’Anna of Pisa

    (Guest speech 1) Professor Gordon Cheng, Technical University of Munich

    (Guest speech 2) Professor Cecilia Laschi, National University of Singapore

Session 3: Panel discussion 1 Work and everyday lifestyles with CAs in 2050

Session 4: Panel discussion 2 Building nano- to socioscopic CA infrastructure

Details of the symposium can be found at the official website and the note.

Official website: https://www.jst.go.jp/moonshot/sympo/20220930/index.html

The note: https://note-moonshot.jst.go.jp/n/n6fc1499c0dcc



Share12Tweet8Share2ShareShareShare2

Related Posts

Humans and Zebra Finches Share Similar Speech Learning Techniques #ASA190 — Chemistry

Humans and Zebra Finches Share Similar Speech Learning Techniques #ASA190

May 11, 2026
New Study Uncovers How Fungal Parasites Attack Strawberries and Raspberries — Agriculture

New Study Uncovers How Fungal Parasites Attack Strawberries and Raspberries

May 11, 2026

City of Hope Researchers to Present Groundbreaking Immunotherapy and Precision Medicine Advances Across Multiple Cancer Types at ASCO 2026

May 11, 2026

Medicaid Expansion Reduces Mortality in Young Adults with Kidney Failure

May 11, 2026

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    841 shares
    Share 336 Tweet 210
  • New Study Reveals Plants Can Detect the Sound of Rain

    728 shares
    Share 290 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Humans and Zebra Finches Share Similar Speech Learning Techniques #ASA190

New Study Uncovers How Fungal Parasites Attack Strawberries and Raspberries

City of Hope Researchers to Present Groundbreaking Immunotherapy and Precision Medicine Advances Across Multiple Cancer Types at ASCO 2026

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.